Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04960826

Study of an Environmental Risk Factor in Crohn's Disease

dEoxyniValenol as Risk Factor for Inflammatory Bowel Diseases: Human detoxifiCaTion and Impact On intestiNal Microbiota and Homeostasis

Status
Recruiting
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
University Hospital, Lille · Academic / Other
Sex
All
Age
25 Years – 60 Years
Healthy volunteers
Accepted

Summary

Inflammatory bowel disease (IBD) are lifelong chronic diseases affecting the gastrointestinal tract. The precise etiology and the different actors participating to the pathophysiological process leading to the disease development are still not well understood. A complex interaction between genetics, gut microbiota and environmental factors is thought to trigger the inappropriate mucosal immune response observed in IBD patients. We hypothesize that DON might be an environmental risk factor for IBD.The focus on the human relevance of the gut effects of DON by studying its exposure, metabolism and adverse effects in health and disease focusing on IBD patients

Conditions

Timeline

Start date
2021-09-27
Primary completion
2026-07-01
Completion
2026-07-01
First posted
2021-07-14
Last updated
2025-12-26

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04960826. Inclusion in this directory is not an endorsement.